Your Health, We Care
During treatment with LuciDarax(Daraxonrasib), please follow your doctor's instructions for follow-up visits and imaging assessments. Do not increase the dose or stop the drug ···【more】
Article source：Lucius LaosRelease date：2026-10-10Recommended：234
LuciDarax(Daraxonrasib) was approved by the U.S. FDA on August 26, 2026, under the brand name RASONQUE. It is the first oral targeted drug approved in the United States that direct···【more】
Article source：Lucius LaosRelease date：2026-10-10Recommended：249
Daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have had ≥1 prior therapy or cannot receive combination anticancer therapy.【more】
Article source：Lucius LaosRelease date：2026-10-10Recommended：75
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
